Not only PPAR-γ agonists downregulate both the PI3K and the Ras pathway, which are the two main signaling pathways downstream receptors of the IGF system, but also they ameliorate insulin resistance and lower circulating levels of insulin and free IGF-I. This evidence concerns the gene IGF1 and Insulin resistance.